These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 12639076)

  • 1. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.
    Ezekowitz JA; Armstrong PW; McAlister FA
    Ann Intern Med; 2003 Mar; 138(6):445-52. PubMed ID: 12639076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable defibrillators versus medical therapy for cardiac channelopathies.
    McNamara DA; Goldberger JJ; Berendsen MA; Huffman MD
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD011168. PubMed ID: 26445202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Stavrakis S; Asad Z; Reynolds D
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone versus other pharmacological interventions for prevention of sudden cardiac death.
    Claro JC; Candia R; Rada G; Baraona F; Larrondo F; Letelier LM
    Cochrane Database Syst Rev; 2015 Dec; 2015(12):CD008093. PubMed ID: 26646017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.
    Hilleman DE; Bauman AL
    Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysis.
    Kolodziejczak M; Andreotti F; Kowalewski M; Buffon A; Ciccone MM; Parati G; Scicchitano P; Uminska JM; De Servi S; Bliden KP; Kubica J; Bortone A; Crea F; Gurbel P; Navarese EP
    Ann Intern Med; 2017 Jul; 167(2):103-111. PubMed ID: 28632280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficiencies and Complications of Dual Chamber versus Single Chamber Implantable Cardioverter Defibrillators in Secondary Sudden Cardiac Death Prevention: A Meta-analysis.
    Hu ZY; Zhang J; Xu ZT; Gao XF; Zhang H; Pan C; Chen SL
    Heart Lung Circ; 2016 Feb; 25(2):148-54. PubMed ID: 26338316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic review: implantable cardioverter defibrillators for adults with left ventricular systolic dysfunction.
    Ezekowitz JA; Rowe BH; Dryden DM; Hooton N; Vandermeer B; Spooner C; McAlister FA
    Ann Intern Med; 2007 Aug; 147(4):251-62. PubMed ID: 17709759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of QRS duration on survival benefit with prophylactic implantable cardioverter-defibrillators: a meta-analysis of randomized controlled trials.
    Sipahi I; Chaudhry SP; Issa M; Ambati M; Dagdelen S; Fang JC
    J Cardiovasc Med (Hagerstown); 2015 Dec; 16(12):811-6. PubMed ID: 25010502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality Implications of Appropriate Implantable Cardioverter Defibrillator Therapy in Secondary Prevention Patients: Contrasting Mortality in Primary Prevention Patients From a Prospective Population-Based Registry.
    Almehmadi F; Porta-Sánchez A; Ha ACT; Fischer HD; Wang X; Austin PC; Lee DS; Nanthakumar K
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28862957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-benefit analysis of primary prevention of sudden cardiac death with an implantable cardioverter defibrillator versus amiodarone in Canada.
    Deniz HB; Ward A; Jaime Caro J; Alvarez P; Sadri H
    Curr Med Res Opin; 2009 Mar; 25(3):617-26. PubMed ID: 19232036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
    Tan VH; Wilton SB; Kuriachan V; Sumner GL; Exner DV
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):164-70. PubMed ID: 24446023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis.
    Al-Khatib SM; Fonarow GC; Joglar JA; Inoue LYT; Mark DB; Lee KL; Kadish A; Bardy G; Sanders GD
    JAMA Cardiol; 2017 Jun; 2(6):685-688. PubMed ID: 28355432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device Therapy for Sudden Cardiac Death Prophylaxis After Acute Coronary Syndrome: When and Why?
    Beg F; Valderrabano M; Schurmann P
    Curr Cardiol Rep; 2020 Jan; 22(1):4. PubMed ID: 31950276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis.
    Theuns DA; Smith T; Hunink MG; Bardy GH; Jordaens L
    Europace; 2010 Nov; 12(11):1564-70. PubMed ID: 20974768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.
    Maron BJ; Spirito P; Ackerman MJ; Casey SA; Semsarian C; Estes NA; Shannon KM; Ashley EA; Day SM; Pacileo G; Formisano F; Devoto E; Anastasakis A; Bos JM; Woo A; Autore C; Pass RH; Boriani G; Garberich RF; Almquist AK; Russell MW; Boni L; Berger S; Maron MS; Link MS
    J Am Coll Cardiol; 2013 Apr; 61(14):1527-35. PubMed ID: 23500286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic implantable cardioverter defibrillator therapy in high-risk patients with coronary artery disease.
    Kolettis TM; Saksena S
    Am Heart J; 1994 Apr; 127(4 Pt 2):1164-70. PubMed ID: 7909188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
    Akel T; Lafferty J
    Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28129469
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.